Maribel Díaz-Ricart

Grup de recerca

Hemoteràpia - hemostàsia Group leader (R4)

mdiaz@clinic.cat 0000-0003-1122-0052

Publicacions destacades

Progressive endothelial cell damage in correlation with sepsis severity

Autors:
Fernández, S; Palomo, M; Molina, P; Díaz-Ricart, M; Escolar, G;

(...)

Torramade-Moix, S; Rovira, M; Carreras, E; Nicolás, JM; Castro, P.

Referència: Journal Of Thrombosis And Haemostasis 2021.
Apixaban Downregulates Endothelial Inflammatory and Prothrombotic Phenotype in an In Vitro Model of Endothelial Dysfunction in Uremia

Autors:
Torramade-Moix, Sergi; Palomo, Marta; Vera, Manel; Jerez, Didac; Moreno-Castano, Ana Belen;

(...)

Diekmann, Fritz; Garcia-Pagan, Joan Caries; Escolar, Gines; Cases, Aleix; Diaz-Ricart, Maribel.

Referència: Cardiovascular Drugs And Therapy 2021.
Complement as the enabler of carfilzomib-induced thrombotic microangiopathy

Autors:
Blasco, M; Martínez-Roca, A; Rodríguez-Lobato, LG; Garcia-Herrera, A; Rosiñol, L;

(...)

Guillen, E; Campistol, JM; Carreras, E; Diaz-Ricart, M; Palomo, M.

Referència: British Journal Of Haematology 2021.
Complement and coagulation cascades activation is the main pathophysiological pathway in early-onset severe preeclampsia revealed by maternal proteomics

Autors:
Youssef, Lina; Miranda, Jezid; Blasco, Miquel; Paules, Cristina; Crovetto, Francesca;

(...)

Maria Campistol, Josep; Carles Garcia-Pagan, Joan; Diaz-Ricart, Maribel; Gratacos, Eduard; Crispi, Fatima.

Referència: Scientific Reports 2021.
The induction strategies administered in the treatment of multiple myeloma exhibit a deleterious effect on the endothelium

Autors:
Martinez-Sanchez J; Palomo M; Torramade-Moix S; Moreno-Castaño AB; Rovira M;

(...)

Escolar G; Penack O; Rosiñol L; Carreras E; Diaz-Ricart M.

Referència: Bone Marrow Transplantation 2020.
Endothelial damage, inflammation and immunity in chronic kidney disease

Autors:
Diaz-Ricart M; Torramade-Moix S; Pascual G; Palomo M; Moreno-Castaño AB;

Martinez-Sanchez J; Vera M; Cases A; Escolar G.

Referència: Toxins 2020.
Up-regulation of HDACs, a harbinger of uraemic endothelial dysfunction, is prevented by defibrotide

Autors:
Palomo, Marta; Vera, Manel; Martin, Susana; Torramade-Moix, Sergi; Martinez-Sanchez, Julia;

Moreno, Ana Belen; Carreras, Enric; Escolar, Gines; Cases, Aleix; Diaz-Ricart, Maribel;.

Referència: Journal Of Cellular And Molecular Medicine 2020.
Complement Activation and Thrombotic Microangiopathies.

Autors:
Palomo M; Blasco M; Molina P; Lozano M; Praga M;

(...)

Manonelles A; Gratacos E; Pereira A; Campistol JM; Diaz-Ricart M .

Referència: Clinical Journal Of The American Society Of Nephrology 2019.
Acute Graft-vs.-Host Disease-Associated Endothelial Activation in vitro Is Prevented by Defibrotide

Autors:
Martinez-Sanchez J; Hamelmann H; Palomo M; Mir E; Moreno-Castaño AB;

(...)

Mertlitz S; Riesner K; Carreras E; Penack O; Diaz-Ricart M.

Referència: Frontiers In Immunology 2019.
Endothelial damage is aggravated in acute GvHD and could predict its development.

Autors:
Mir E; Palomo M; Rovira M; Pereira A; Escolar G;

Penack O; Holler E; Carreras E; Diaz-Ricart M .

Referència: Bone Marrow Transplantation 2017.

Projectes destacats

Protection of the endothelium during steroid-refractory GVHD. 03R/2019. CoIP w

Investigador/a principal: ENRIQUE CARRERAS PONS

Finançador: Instituto de Investigación contra la leucemia Josep Carreras (Sede o evento)

Durada: 01/11/2019 - 31/10/2021
Grupo de Fisiología, Hemostasia y Trombosis. 2017-SGR671. Investigador Asociado

Finançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento)

Durada: 01/01/2018 - 31/12/2020
Microchips para la evaluación global de la hemostasia en la cabecera del paciente (POC): Aplicaciones en la detección de alteraciones y en el seguimiento de las terapias antitrombóticas. DTS16/00133. Investigador Asociado.

Finançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento)

Durada: 01/01/2017 - 31/12/2018
Enhancement of endothelial regeneration and endothelial funcion during graft versus host disease. 11R/2016. CoIP w

Investigador/a principal: ENRIQUE CARRERAS PONS

Finançador: Instituto de Investigación contra la leucemia Josep Carreras (Sede o evento)

Durada: 01/11/2016 - 31/10/2019
Effects of apixaban beyond anticoagulation: potential protective role on endothelial dysfunction. ERISTA15. IP.

Investigador/a principal: M.ISABEL DIAZ RICART

Finançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento)

Durada: 01/01/2016 - 31/12/2017

Maribel Díaz-Ricart

Grup de recerca

Publicacions destacades

Projectes destacats

Protection of the endothelium during steroid-refractory GVHD. 03R/2019. CoIP w

Grupo de Fisiología, Hemostasia y Trombosis. 2017-SGR671. Investigador Asociado

Microchips para la evaluación global de la hemostasia en la cabecera del paciente (POC): Aplicaciones en la detección de alteraciones y en el seguimiento de las terapias antitrombóticas. DTS16/00133. Investigador Asociado.

Enhancement of endothelial regeneration and endothelial funcion during graft versus host disease. 11R/2016. CoIP w

Effects of apixaban beyond anticoagulation: potential protective role on endothelial dysfunction. ERISTA15. IP.

Subscriu-te a la Newsletter del Clínic